(Q39503048)

12 September 2017

Prevention of acute porphyric attacks by intravenous haematin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79864

4 November 2022

author name string

J. M. Lamon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79864

4 November 2022

B. C. Frykholm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79864

4 November 2022

M. Bennett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79864

4 November 2022

D. P. Tschudy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79864

4 November 2022

language of work or name

English

0 references

publication date

1 September 1978

1 reference

12 September 2017

2 September 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=79864

full work available at URL

4 November 2022

https://api.elsevier.com/content/article/PII:S0140673678922171?httpAccept=text/xml

1 reference

10.1016/S0140-6736(78)92217-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(78)92217-1

https://api.elsevier.com/content/article/PII:S0140673678922171?httpAccept=text/plain

4 November 2022

1 reference

10.1016/S0140-6736(78)92217-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(78)92217-1

4 November 2022

1 reference

12 September 2017

2

1 reference

12 September 2017

8088

1 reference

12 September 2017

492-494

1 reference

Acute Intermittent Porphyria: Clinical and Selected Research Aspects

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

Repression of the Overproduction of Porphyrin Precursors in Acute Intermittent Porphyria by Intravenous Infusions of Hematin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

1 reference

7 January 2021

Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992217-1

7 January 2021

10.1016/S0140-6736(78)92217-1

Identifiers

DOI

1 reference

12 September 2017

1 reference